The 3M Harvest RC clarifier condenses three process steps into a single-stage purification of recombinant protein therapeutics.
The 3M Harvest RC clarifier from 3M Health Care uses a proprietary fibrous chromatography media to condense three process steps into a single-stage purification of recombinant protein therapeutics.
The clarifier provides monoclonal antibody recovery of more than 95% and can be used with cultures with different cell densities, high-packed cell volumes, and cell culture characteristics. The quaternary ammonium functionalized polypropylene fiber, and 0.2 µm PES membrane, provides scalable clarification from discovery to commercial manufacturing scale.
The clarifier introduces chromatographic separation earlier in the process to remove soluble impurities, resulting in cleaner effluent, the company reports.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.